


Reset Pharmaceuticals Revenue
Biotechnology Research • United States • 1-10 Employees
Reset Pharmaceuticals revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | $11,100,000 |
Key Contact at Reset Pharmaceuticals
Greg Mckee
Member Board of Directors
Company overview
| Headquarters | United States |
| Phone number | +12020117456 |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
| Socials |
Reset Pharmaceuticals Email Formats
Reset Pharmaceuticals uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@resetpharma.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@resetpharma.com | 100% |
About Reset Pharmaceuticals
Reset Pharma is a privately-held biotechnology company focused on the development and commercialization of novel psychedelic treatments for patients with life-threatening illnesses, including cancer. The company’s lead program focuses on psilocybin with psychotherapy for patients with cancer related demoralization, anxiety and depression. Reset Pharma has established a highly experienced biotech development team and has a Scientific Advisory Board of leading experts in psychiatry, oncology and psychedelics.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Reset Pharmaceuticals Tech Stack
Discover the technologies and tools that power Reset Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.
UI frameworks
JavaScript libraries
JavaScript libraries
JavaScript libraries
CDN
JavaScript libraries
Miscellaneous
Programming languages
Blogs
Analytics
Miscellaneous
Frequently asked questions
4.8
40,000 users



